 |
LEATHERHEAD, England, July 4, 2025 /PRNewswire/ -- MatOrtho® is proud to announce that the ReCerf® Hip Resurfacing Arthroplasty (HRA) has received its CE mark, confirming compliance with European safety and performance standards. This important milestone expands access to hip resurfacing, enabling wider availability across the UK, Europe and internationally where CE marking supports market access.
"This is more than a regulatory milestone. It represents two decades of focused effort to improve hip resurfacing through an advanced material," said Mike Tuke, Founder of MatOrtho. "That became a possibility with BIOLOX® delta and cooperation with CeramTec A.G. which led in stages to ReCerf – an all-ceramic resurfacing implant that is already delivering excellent results. We're proud to make this more widely available to specialist hip resurfacing surgeons, and patients who want to stay active."
ReCerf is the world's first commercially available ceramic HRA, first approved by Australia's Therapeutic Goods Administration in November 2024. Since its initial use in 2018, over 1,600 patients have received the device. Patient-reported outcomes are highly positive, and the revision rate remains very low up to six years.
Made from BIOLOX® delta ceramic, ReCerf eliminates concerns historically associated with metal-on-metal bearings and preserves more of the patient's natural bone. For surgeons, it offers a familiar procedure underpinned by improved materials, and is supported by a company long recognised as the home of modern hip resurfacing.
ReCerf's availability under CE marking is matched by a strong commitment to responsible adoption. MatOrtho supports structured education, careful patient selection, and ongoing clinical monitoring. A peer-led surgeon training programme is already in place to ensure safe and effective use.
This achievement strengthens MatOrtho's strategic growth and reaffirms its leadership in pioneering orthopaedic solutions designed to restore normal joint function and support high level activity.
For more information visit: www.ReCerf.com
About MatOrtho:
MatOrtho (formerly Finsbury Orthopaedics) is a global leader in orthopaedic invention and innovation, committed to advancing joint replacement technologies that improve patient outcomes and set new clinical standards.
Website: www.matortho.com/recerf
LEATHERHEAD, England, July 4, 2025 /PRNewswire/ -- MatOrtho® is proud to announce that the ReCerf® Hip Resurfacing Arthroplasty (HRA) has received its CE mark, confirming compliance with European safety and performance standards. This important milestone expands access to hip resurfacing, enabling wider availability across the UK, Europe and internationally where CE marking supports market access.
"This is more than a regulatory milestone. It represents two decades of focused effort to improve hip resurfacing through an advanced material," said Mike Tuke, Founder of MatOrtho. "That became a possibility with BIOLOX® delta and cooperation with CeramTec A.G. which led in stages to ReCerf – an all-ceramic resurfacing implant that is already delivering excellent results. We're proud to make this more widely available to specialist hip resurfacing surgeons, and patients who want to stay active."
ReCerf is the world's first commercially available ceramic HRA, first approved by Australia's Therapeutic Goods Administration in November 2024. Since its initial use in 2018, over 1,600 patients have received the device. Patient-reported outcomes are highly positive, and the revision rate remains very low up to six years.
Made from BIOLOX® delta ceramic, ReCerf eliminates concerns historically associated with metal-on-metal bearings and preserves more of the patient's natural bone. For surgeons, it offers a familiar procedure underpinned by improved materials, and is supported by a company long recognised as the home of modern hip resurfacing.
ReCerf's availability under CE marking is matched by a strong commitment to responsible adoption. MatOrtho supports structured education, careful patient selection, and ongoing clinical monitoring. A peer-led surgeon training programme is already in place to ensure safe and effective use.
This achievement strengthens MatOrtho's strategic growth and reaffirms its leadership in pioneering orthopaedic solutions designed to restore normal joint function and support high level activity.
For more information visit: www.ReCerf.com
About MatOrtho:
MatOrtho (formerly Finsbury Orthopaedics) is a global leader in orthopaedic invention and innovation, committed to advancing joint replacement technologies that improve patient outcomes and set new clinical standards.
Website: www.matortho.com/recerf
** The press release content is from PR Newswire. Bastille Post is not involved in its creation. **
ReCerf Receives its CE Mark, Advancing Access to Ceramic Hip Resurfacing Across Europe
LAS VEGAS, Jan. 9, 2026 /PRNewswire/ -- Guide Sensmart (Booth 21740, Central Hall), a global leader in thermal imaging technology, officially launched its next-generation thermal imaging innovation – ApexVision – alongside a series of new products empowered by the technology. This launch represents a systemic leap for the industry from merely "seeing heat" to "seeing with clarity, precision, and intelligence," marking the dawn of a new era defined by Ultra-Clarity.
CES Show Floor Reaction: "Ultra-Clarity" Draws Deep Engagement
At the Guide Sensmart booth, live product demonstrations powered by ApexVision attracted strong attention from industry analysts to global media. Hands-on comparisons—such as maintaining clear imaging details of distant targets and delivering crisp, smear-free imaging of fast-moving objects—earned consistent praise. Many professional visitors noted that this reliable "what-you-see-is-what-you-get" clarity would directly enhance operational efficiency and decision-making confidence.
ApexVision integrating both hardware and software: It combines the high-sensitivity ApexCore S1 detector, the Nexus 1.0 processing platform, and scenario-optimized algorithms. Together, ApexVision successfully overcomes persistent challenges such as low contrast in complex environments, detail loss at long range or high magnification, motion blur on fast-moving objects, and inaccurate detection of minute temperature differences.
From Architecture to Application: A Full Portfolio Empowered
On the CES show floor, Guide Sensmart demonstrated how ApexVision delivers tangible improvements across thermal devices. Thermography tools (e.g. E3S, H6S thermal cameras) leverage the SharpIR 2.0 algorithm to provide stable, accurate temperature measurement in demanding environments, enabling inspectors to pinpoint hidden faults with greater confidence. Outdoor hunting optics (e.g. TD650LS monocular and TN650MS binocular), benefit from Hyper-Light 2.0, allowing users to identify nocturnal wildlife in complete darkness and track fast-moving targets while maintaining clean, sharp images even at 10× zoom.
"The launch of ApexVision marks a milestone where our vertically integrated technology development translates into real value for users," said a Guide Sensmart spokesperson. "It is more than a set of specifications—it delivers the certainty of Ultra-Clarity to every professional user."
The debut of ApexVision at CES 2026 signifies more than a routine product update. By resolving long-standing trade-offs between sensitivity, stability, and environmental robustness, Guide Sensmart is advancing thermal imaging into the Ultra-Clarity Era, building a clearer, safer, and more efficient future.
We are keen to explore partnership of collaboration with you. Know more about Guide Sensmart at https://www.guideir.com.
** The press release content is from PR Newswire. Bastille Post is not involved in its creation. **
ApexVision Debuts at CES 2026: Guide Sensmart Ushers in the Ultra-Clarity Era of Thermal Imaging
